145 related articles for article (PubMed ID: 26762784)
1. Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord.
Milne M; Ashton JC
Neurosci Lett; 2016 Feb; 614():39-42. PubMed ID: 26762784
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
4. Endovanilloids are potential activators of the trigeminovascular nocisensor complex.
Dux M; Deák É; Tassi N; Sántha P; Jancsó G
J Headache Pain; 2016; 17():53. PubMed ID: 27189587
[TBL] [Abstract][Full Text] [Related]
5. Opposing effects of cannabinoids and vanilloids on evoked quantal release at the frog neuromuscular junction.
Silveira PE; Silveira NA; Morini Vde C; Kushmerick C; Naves LA
Neurosci Lett; 2010 Apr; 473(2):97-101. PubMed ID: 20176082
[TBL] [Abstract][Full Text] [Related]
6. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
7. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
8. The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Ellington HC; Cotter MA; Cameron NE; Ross RA
Neuropharmacology; 2002 Jun; 42(7):966-75. PubMed ID: 12069907
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
10. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
Shiri M; Komaki A; Oryan S; Taheri M; Komaki H; Etaee F
Can J Physiol Pharmacol; 2017 Apr; 95(4):382-387. PubMed ID: 28112976
[TBL] [Abstract][Full Text] [Related]
11. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
Ahluwalia J; Urban L; Bevan S; Nagy I
Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
[TBL] [Abstract][Full Text] [Related]
12. Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation.
Mogg AJ; Mill CE; Folly EA; Beattie RE; Blanco MJ; Beck JP; Broad LM
Br J Pharmacol; 2013 Feb; 168(4):1015-29. PubMed ID: 23062150
[TBL] [Abstract][Full Text] [Related]
13. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves.
Breyne J; Vanheel B
J Cardiovasc Pharmacol; 2006 Feb; 47(2):303-9. PubMed ID: 16495770
[TBL] [Abstract][Full Text] [Related]
14. Different effects of opioid and cannabinoid receptor agonists on C-fiber-induced extracellular signal-regulated kinase activation in dorsal horn neurons in normal and spinal nerve-ligated rats.
Kawasaki Y; Kohno T; Ji RR
J Pharmacol Exp Ther; 2006 Feb; 316(2):601-7. PubMed ID: 16221738
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain.
Schuelert N; Zhang C; Mogg AJ; Broad LM; Hepburn DL; Nisenbaum ES; Johnson MP; McDougall JJ
Osteoarthritis Cartilage; 2010 Nov; 18(11):1536-43. PubMed ID: 20863899
[TBL] [Abstract][Full Text] [Related]
16. Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids.
Hoffman AF; Lupica CR
J Neurophysiol; 2001 Jan; 85(1):72-83. PubMed ID: 11152707
[TBL] [Abstract][Full Text] [Related]
17. The cannabinoid receptor agonists, anandamide and WIN 55,212-2, do not directly affect mu opioid receptors expressed in Xenopus oocytes.
Kracke GR; Stoneking SP; Ball JM; Tilghman BM; Washington CC; Hotaling KA; Johnson JO; Tobias JD
Naunyn Schmiedebergs Arch Pharmacol; 2007 Dec; 376(4):285-93. PubMed ID: 17960365
[TBL] [Abstract][Full Text] [Related]
18. Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.
Brownjohn PW; Ashton JC
Neuroscience; 2012 Feb; 203():180-93. PubMed ID: 22210507
[TBL] [Abstract][Full Text] [Related]
19. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
20. Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation.
Tognetto M; Amadesi S; Harrison S; Creminon C; Trevisani M; Carreras M; Matera M; Geppetti P; Bianchi A
J Neurosci; 2001 Feb; 21(4):1104-9. PubMed ID: 11160380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
